MedPath

Advance care planning (ACP) in incurable cancer patients with disease progression on first line chemotherapy: a randomised trial

Not Applicable
Conditions
Cancer
end of life decision making
Cancer - Any cancer
Public Health - Health service research
Registration Number
ACTRN12613001288718
Lead Sponsor
The University of Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
668
Inclusion Criteria

Diagnosis of an incurable cancer with disease progression on first line chemotherapy and an expected median survival of less than 12 months.
Able to nominate one (only) family member or friend who is willing to participate in the study
18 years of age or over
Able to read and write English
Able and well enough to read a booklet and complete some questionnaires (e.g. can’t be confused)

Exclusion Criteria

Previous formal advance care planning

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Documentation of patients end of life wishes and compliance with known end of life wishes measured by medical record review and standardized study developed scoring system.[Within 3 weeks of the patients death]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath